On Monday, September 26 and Tuesday, September 27, 2016, instrumentation in the core clinical laboratory will be impacted by construction project.  This may cause general delays in laboratory testing.  There will be extended delays for the following assays:

Alpha 1 Antitrypsin (LAB927)
Angiotensin - 1 Converting Enzyme (LAB563)
Amikacin Drug Level (LAB555)
Beta-2 Microglobulin (LAB49)
Bile Acids, Total (LAB2713)
C3 Complement (LAB152)
C4 Complement (LAB151)
Carbamazepine Drug Level (LAB22)
Cardiac CRP (LAB150)
Ceruloplasmin (LAB582)
Cystatin C (LAB2967)
Ethylene Glycol, Plasma (LAB7453)
Everolimus Drug Level (LAB7456)
Folate (Folic Acid) (LAB69)
Homocysteine (LAB93)
Keppra (Levetriracetam) Drug Level (LAB477)
Lamotrigine (Lamictal) Drug Level (LAB475)
Lidocaine Drug Level (LAB641)
Myoglobin (LAB105)
Myoglobin, Urine (LAB8102)
Pentobarbital Drug Level (LAB656)
Phenytoin Free Drug Level (LAB32)
Phenobarbital Drug Level (LAB30)
Rheumatoid Factor (LAB206)
Soluble Transferrin Receptor (LAB906)
Nicotine Metabolite, Rapid Screen (LAB8071)
Valproic Acid Drug Level (LAB25)

Please contact Specimen Control (356-3527) for more information on specific assays. There is limited ability to run some of the assays above at the VA Hospital clinical laboratory upon request.

Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380, matthew-krasowski@uiowa.edu).